Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.070
+0.110 (5.61%)
At close: Jan 9, 2026, 4:00 PM EST
2.120
+0.050 (2.42%)
After-hours: Jan 9, 2026, 7:34 PM EST
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $141.77 million as of January 9, 2026. Its market cap has increased by 83.26% in one year.
Market Cap
141.77M
Enterprise Value
204.54M
1-Year Change
83.26%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $141.77M, a decrease of -69.50%. That is a compound annual growth rate of -14.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 134.23M | 42.03% |
| Dec 31, 2025 | 94.51M | 5.48% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |